ARM

Arm Holdings plc American Depositary Shares

67
Fundamentals66/ 100
Valuation56/ 100
Upside potential74/ 100
Risk potential28/ 100

ARM has a slight edge over ORCL overall, supported by stronger fundamentals and stronger modeled upside.

ORCL

Oracle Corporation

65
Fundamentals60/ 100
Valuation78/ 100
Upside potential73/ 100
Risk potential19/ 100

ORCL has lower modeled downside risk, despite its lower overall score.

ARM Fundamentals

MetricStatus
Healthy
Healthy
Strong
Strong

ARM's revenue, profitability, cash flow and balance sheet are all currently healthy.

ORCL Fundamentals

MetricStatus
Healthy
Strong
Weak
Strong

ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

ARM PE Valuation

CHEAPFAIREXPENSIVE160x321x481x642x
CHEAPFAIREXPENSIVE160x321x481x642x
LevelPEPriceVs current
Cheap167x$147-27%
Fair224x$197-1.4%
Current227x$200—
Expensive361x$317+59%

Historical ranges are pointers, not guarantees.

ARM's PE is in its fair range at 227x.

ORCL PE Valuation

CHEAPFAIREXPENSIVE19x37x56x74x
CHEAPFAIREXPENSIVE19x37x56x74x
LevelPEPriceVs current
Forward15x$127—
Cheap19x$119-6.8%
Current20x$127—
Fair30x$189+49%
Expensive39x$247+94%

Historical ranges are pointers, not guarantees.

ORCL has the edge over ARM in the historical PE scenario, which offers more potential upside but is not a forecast.

ARM Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Improving
Moderate
Moderate

ARM has the edge over ORCL on the outlook, with more favorable profitability expectations.

ORCL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly weakening
Moderate
High

Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.

ARM Risk to reward

ScenarioChangePrice
Upside+80%$358.92
Downside-28%$143.85

Calculated from the latest close: $199.78 on Nov 12.

ARM has a better modeled risk to reward balance than ORCL, with more potential upside relative to its potential downside.

ORCL Risk to reward

ScenarioChangePrice
Upside+52%$192.98
Downside-19%$102.46

Calculated from the latest close: $127.11 on Nov 12.

ORCL trails ARM on modeled risk to reward, with less potential upside relative to its potential downside.

ARM Earnings Per Share

Q4 2023: $0.08Q1 2024: $0.29Q3 2024: $0.60Q4 2024: $0.76Q1 2025: $0.75Q2 2025: $0.66Q3 2025: $0.78Q4 2025: $0.75Q1 2026: $0.85Q2 2026: $0.98Q3 2026: $0.88
Q4 2023: $0.08Q1 2024: $0.29Q3 2024: $0.60Q4 2024: $0.76Q1 2025: $0.75Q2 2025: $0.66Q3 2025: $0.78Q4 2025: $0.75Q1 2026: $0.85Q2 2026: $0.98Q3 2026: $0.88
QuarterTTM EPSYoY
Q3 2026$0.88+13%
Q2 2026$0.98+48%
Q1 2026$0.85+13%
Q4 2025$0.75-1.3%
Q3 2025$0.78+30%
Q1 2025$0.75+159%
Q4 2024$0.76+850%
Q3 2024$0.60+233%

ARM earned $0.88 per share over the past year, up 13% from the year before.

ORCL Earnings Per Share

Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
QuarterTTM EPSYoY
Forward$8.53+34%
Q3 2026$6.38+48%
Q2 2026$5.83+34%
Q1 2026$5.57+31%
Q4 2025$5.32+30%
Q3 2025$4.32+11%
Q2 2025$4.34+17%
Q1 2025$4.26+12%
Q4 2024$4.09+13%

ORCL has the edge over ARM on earnings, with more consistent year-over-year improvement.

ARM Quarterly Revenue

Q4 2023: $824MQ1 2024: $928MQ2 2024: $939MQ3 2024: $844MQ4 2024: $983MQ1 2025: $1.2BQ2 2025: $1.1BQ3 2025: $1.1BQ4 2025: $1.2BQ1 2026: $1.5BQ2 2026: $1.3BQ3 2026: $1.4B
Q4 2023: $824MQ1 2024: $928MQ2 2024: $939MQ3 2024: $844MQ4 2024: $983MQ1 2025: $1.2BQ2 2025: $1.1BQ3 2025: $1.1BQ4 2025: $1.2BQ1 2026: $1.5BQ2 2026: $1.3BQ3 2026: $1.4B
QuarterRevenueYoY
Q3 2026$1.4B+27%
Q2 2026$1.3B+22%
Q1 2026$1.5B+20%
Q4 2025$1.2B+26%
Q3 2025$1.1B+34%
Q2 2025$1.1B+12%
Q1 2025$1.2B+34%
Q4 2024$983M+19%

ARM has the edge over ORCL on sales, with stronger typical year-over-year growth.

ORCL Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
QuarterRevenueYoY
Q3 2026$19.3B+30%
Q2 2026$19.2B+21%
Q1 2026$17.2B+22%
Q4 2025$16.1B+14%
Q3 2025$14.9B+12%
Q2 2025$15.9B+11%
Q1 2025$14.1B+6.4%
Q4 2024$14.1B+8.6%

ORCL's revenue has grown year over year for 13 quarters in a row: $19.3B last quarter, up 30% from the same quarter a year ago.

ARM Free Cash Flow

Q4 2023: $289MQ1 2024: $656MQ2 2024: −$319MQ3 2024: −$47MQ4 2024: $360MQ1 2025: $184MQ2 2025: $178MQ3 2025: $429MQ4 2025: $186MQ1 2026: $186MQ2 2026: $705MQ3 2026: $135M
Q4 2023: $289MQ1 2024: $656MQ2 2024: −$319MQ3 2024: −$47MQ4 2024: $360MQ1 2025: $184MQ2 2025: $178MQ3 2025: $429MQ4 2025: $186MQ1 2026: $186MQ2 2026: $705MQ3 2026: $135M
QuarterFree cash flowYoY
Q3 2026$135M-69%
Q2 2026$705M+296%
Q1 2026$186M+1.1%
Q4 2025$186M-48%
Q3 2025$429M+$476M
Q2 2025$178M+$497M
Q1 2025$184M-72%
Q4 2024$360M+25%

ARM has the edge over ORCL on cash generation, producing positive trailing cash flow while its opponent burns cash.

ORCL Free Cash Flow

Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
QuarterFree cash flowYoY
Q3 2026-$5.4B-$5B
Q2 2026-$1.9B+$1.1B
Q1 2026-$11.5B-16275%
Q4 2025-$10B-$7.3B
Q3 2025-$362M-107%
Q2 2025-$2.9B-189%
Q1 2025$71M-98%
Q4 2024-$2.7B-$1.7B

ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.

ARM Total Shares

Q4 2023: 1BQ1 2024: 1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
Q4 2023: 1BQ1 2024: 1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
PeriodChange %Net change
Quarterly+0.1%+1M shares
1 year+0.9%+10M shares
3 years+5.2%+53.7M shares

ARM has the edge over ORCL on shareholder dilution, with a more favorable share count trend.

ORCL Total Shares

Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
PeriodChange %Net change
Quarterly+3%+86M shares
1 year+3.1%+91M shares
3 years+6.3%+177M shares
5 years+4.9%+139M shares
Available history-9.9%-331M shares

ORCL has 3B diluted shares, up 3.1% from a year ago.

ARM Net Leverage

QuarterNet LeverageStatus
Q1 2023-1.6xNet Cash

ARM has more cash than debt.

ORCL Net Leverage

Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
QuarterNet LeverageStatus
Q3 2026-0.9xNet Cash
Q2 20263.5xElevated
Q1 20260.5xVery low
Q4 20250.3xVery low
Q3 2025-0.1xNet Cash
Q2 20253.7xElevated
Q1 20250.2xVery low
Q4 20240.2xVery low

ORCL has more cash than debt.

ARM Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic11.0Oversold

ARM's weekly RSI is 43 (neutral) and its Stochastic is 11 (oversold).

ORCL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic23.0Neutral

ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

ARM PE vs Technology Sector

MetricARMSector medianRelative
PE227x28x715% above
PE %512328 pts above

ARM is trading at 227x earnings, a 715% premium to the Technology sector's median of 28x.

ORCL PE vs Technology Sector

MetricORCLSector medianRelative
PE20x28x28% below
PE %28357 pts below

ORCL has the edge over ARM on valuation relative to its sector.

ARM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$237.816% below
20 week MA$257.322% below
50 week MA$213.96.6% below
100 week MA$176.513% above

ARM has stronger trend alignment. ARM is above 1 of 4 weekly averages versus ORCL above 0 of 5.

ORCL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$131.13.1% below
20 week MA$137.67.7% below
50 week MA$160.321% below
100 week MA$181.430% below
200 week MA$151.916% below

ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.

ARM Yearly ROI

YearStart priceEnd priceROI
2023$60.8$75.2+24%
2024$75.2$129.2+72%
2025$129.2$110.3-15%
2026 YTD$110.3$199.8+81%

ARM has the edge over ORCL on returns for 2026, with the stronger performance.

ORCL Yearly ROI

YearStart priceEnd priceROI
2020$53.5$65.0+22%
2021$65.0$89.7+38%
2022$89.7$80.9-9.9%
2023$80.9$105.4+30%
2024$105.4$169.0+60%
2025$169.0$198.0+17%
2026 YTD$198.0$127.1-36%

ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.

Give your agent the market.

Get API key